NL-OMON49502已完成不适用
COVID-19 and SARS-CoV-2 antibodies in multiple sclerosis patients: a large study in the Amsterdam MS Cohort - COMS-19
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 750
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Under current follow-up in the MS Center Amsterdam
- •Current diagnosis of multiple sclerosis
- •18 years or older
排除标准
- •No informed consent
研究者
相似试验
已完成
不适用
COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis PatientsMultiple SclerosisNCT04498286Zoé van Kempen546
已完成
不适用
SaRS-Cov-2 Antibodies Following Exposure to Coronavirus Disease 2019 (COVID-19) and/or Vaccination in Nursing HomesCOVID-19 InfectionNCT04964024Central Hospital, Nancy, France1,293
已完成
不适用
A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies in Prophylaxis and Curative of Covid-19 (COVIMAB)Immunocompromised PatientsNCT05439044Assistance Publique - Hôpitaux de Paris4,235
已完成
不适用
Corona Immunitas: a nationwide program of antibody studies of SARS-CoV-2 in the Swiss populatioISRCTN18181860Swiss School of Public Health28,000
尚未招募
不适用
Seroprevalence of COVID-19 antibodies among patients living with hemophilia.CTRI/2022/06/043017Maulana Azad Medical College